
Background : Intensive lifestyle modification is central to dyslipidemia management, although pharmacologic therapy is often prioritized when lipid levels are moderately elevated. Similar to quality improvement efforts addressing pre-analytical variables in laboratory medicine—where outcomes depend on structured interventions and patient adherence—the management of hypercholesterolemia likewise requires sustained engagement in non-intuitive but beneficial health behaviors. Case Presentation : A 53-year-old woman with a 2–3-year history of hypercholesterolemia presented with total cholesterol 6.4 mmol/L (247.5 mg/dL), LDL-C 4.0 mmol/L (154.7 mg/dL), HDL-C 1.65 mmol/L (63.8 mg/dL), triglycerides 1.12 mmol/L (99.2 mg/dL), BMI 26.6 kg/m 2 , and blood pressure 95/60 mmHg. She had a family history of diabetes (grandmother), no smoking history, and no premature atherosclerotic cardiovascular disease. Statin therapy was initially recommended. Instead, she implemented a fat-restricted diet emphasizing fruits, vegetables, fish, chicken, and oatmeal, along with 1 hour of exercise 6 days per week. After 2 months, total cholesterol decreased to 5.3 mmol/L (205.0 mg/dL), LDL-C to 3.2 mmol/L (123.7 mg/dL), HDL-C remained stable at 1.63 mmol/L (63.0 mg/dL), triglycerides 0.81 mmol/L (71.69 mg/dL), BMI decreased to 24.7 kg/m 2 , and blood pressure remained stable. Carotid ultrasound showed normal morphology, vessel wall thickness, lumen diameter, and Doppler flow. Statin therapy was no longer recommended. Conclusion : Intensive lifestyle interventions are associated with significant improvements in lipid profiles among carefully selected low-risk patients and may reduce or obviate the need for pharmacologic therapy. Behavioral factors remain integral to the management of dyslipidemia, highlighting the importance of patient-driven modification of cardiovascular risk. Further large-scale, methodologically rigorous studies are warranted to validate the reproducibility and generalizability of these findings.
Prostate cancer is the second most common cancer globally and the fifth leading cause of cancer-related mortality in men, with approximately 1,200,000 new diagnoses and 359,000 deaths recorded in 2018. In Africa, it ranks as the most prevalent cancer, with 40,000 new cases and 28,000 cancer-related deaths annually. In Nigeria, it is the most common malignancy among men, accounting for 29.8% of all male cancers according to GLOBOCAN 2020 statistics. This study assessed the knowledge, attitudes, and practices related to prostate cancer prevention among men aged 20 to 80 years residing in the Okada community. A descriptive cross-sectional survey was conducted among 382 consenting male respondents. The self-administered questionnaire comprised four sections (A–D), addressing socio-demographic characteristics, knowledge of prostate cancer and screening, attitudes toward prostate cancer prevention, and prevention practices, respectively. The results revealed that 52.9% of respondents had inadequate knowledge of prostate cancer and screening. Although 67.8% had previously heard of prostate cancer, 78.5% demonstrated a positive attitude toward screening and prevention, while 84.6% exhibited poor prostate cancer prevention practices. The findings indicated that respondents with higher educational attainment possessed better knowledge of prostate cancer and screening than those with lower or no formal education. Younger men were more likely to express positive attitudes toward prostate cancer prevention. Furthermore, individuals with higher education levels were more likely to engage in effective prostate cancer prevention practices than those with limited or no formal education. Overall, respondents demonstrated inadequate knowledge of prostate cancer and screening, a generally positive attitude toward prevention, but poor preventive practices.
Background Cognitive impairment and dementia are more common in people with type 2 diabetes yet often go undetected. Brief cognitive screening tests could enable earlier identification in routine care, but their diagnostic accuracy and practicality in this population remain uncertain. We systematically reviewed the diagnostic accuracy and feasibility of brief cognitive screening in this population. Methods The review was registered (PROSPERO CRD420261441730) and reported following the PRISMA-DTA guideline. We searched MEDLINE (via PubMed), Embase, CENTRAL and PsycINFO from January 2000 to April 2026, restricted to English-language reports, for studies evaluating a brief cognitive screen against an acceptable reference standard clinical diagnostic criteria or a comprehensive neuropsychological battery or reporting feasibility. Two reviewers independently screened, extracted and appraised studies (QUADAS-2 for accuracy; the Mixed Methods Appraisal Tool for feasibility). Sensitivity and specificity with Wilson 95% confidence intervals were synthesised structurally using paired forest and summary receiver-operating-characteristic plots, and the certainty of evidence was assessed with GRADE. Results Six of 557 records were eligible: four diagnostic-accuracy studies (802 adults) and two feasibility studies. All accuracy studies evaluated the Montreal Cognitive Assessment (MoCA) and one also evaluated the Mini-Mental State Examination (MMSE). At the conventional cut-off (<26) the MoCA was highly sensitive but poorly specific (sensitivity 88-94%, specificity 29-51%); lower, diabetes-specific thresholds improved specificity at the expense of sensitivity (for example 49%/91% at 20/21, and 81%/62% at an optimal 24/25). The single MMSE study showed the reverse profile (66%/96%). Risk of bias was appreciable in every study (incorporation bias, spectrum effects, within-sample thresholds), and a meta-analysis was not appropriate. Two studies supported nurse-delivered screening in primary care (MoCA; and the Mini-Cog, mean 118 seconds, 100% completion). Overall certainty of evidence was low to very low. Conclusions The MoCA is the only brief cognitive screen with replicated accuracy evidence in type 2 diabetes: sensitive but over-referring at the standard cut-off, with a lower threshold better balancing accuracy. Non-specialist screening appears feasible, but the accuracy evidence is limited and at material risk of bias. Diabetes-specific validation against clinical or neuropsychological reference standards is the priority for future research.
Objective: To assess clinicians perspectives on the diagnosis and management of infections in the pediatric intensive care unit (PICU) in India, with a focus on common pathogens, diagnostic and therapeutic approaches, meropenem usage, antimicrobial stewardship, and clinicians' perceptions of the efficacy, safety, and clinical outcomes of meropenem therapy. Methods: Clinicians across India participated in a cross-sectional survey using a structured 23-item questionnaire that assessed pathogen profile, diagnostic and therapeutic practices, meropenem usage, antimicrobial stewardship, and clinicians' perceptions of efficacy, safety, and clinical outcomes. Data were analyzed using descriptive statistics. Results: Among the 205 clinicians who participated in the survey, more than three-quarters (76.59%) identified bacterial infections as the most common cause of pediatric infections in the PICU. Nearly two-thirds (63.90%) reported that newborns and infants were the age group at the highest risk of developing severe infections in the PICU. Most clinicians (78.05%) recognized sepsis as the most common complication associated with ventilator-associated pneumonia in pediatric patients. Additionally, 74% preferred antibiotics as the initial treatment for critically ill pediatric patients with confirmed septic shock. Meropenem was the preferred antimicrobial agent for both empirical and targeted therapy, depending on the clinical scenario, as reported by 80% of respondents. Approximately three-quarters (75.61%) identified inadequate awareness of antibiotic stewardship as the primary factor contributing to the misuse or overuse of meropenem. Furthermore, 87% considered meropenem's broad-spectrum activity against both Gram-positive and Gram-negative organisms to be its greatest therapeutic advantage. Based on the 5-point Global Improvement Scale, 69% reported marked improvement in clinical outcomes following meropenem therapy. Conclusion: The survey emphasizes the importance of early antibiotic therapy, appropriate meropenem use, and antimicrobial stewardship. Meropenem is perceived as an effective broad-spectrum agent, with favorable clinical outcomes reported by most clinicians, supporting its role in the management of severe pediatric infections.
Introduction: The success of kidney transplantation depends on key factors including appropriate patient selection, satisfactory donor compatibility test, early commencement of immunosuppressant and premedication, good surgical technique with experienced transplant team, intensive post-surgery care, serial daily monitoring of renal function, early renal Doppler study as well as continuous immunosuppression and prompt follow up. We report our initial experience at BeWell Kidney Transplant Mission with emphasis on common contemporary indices that influence outcome of kidney transplantation including etiology, patient selection as well as serial outcome amongst donors and recipients following a successful kidney transplant camp. Methodology: This is a prospective observational study involving patients who had kidney transplantation secondary to varying degree of chronic kidney disease over an 8-month period. Structured questionnaire was designed to obtain relevant information. Data analysis was via python 3.x and results represented in tables and charts. Results: A total of 30 kidney transplantation were carried out within the study period. 80% of the recipients were males. All the donors were males. The youngest recipient was 22 years and the oldest was 80 years with a mean age of 61.53 +/- 3.04. Hypertension coexisting diabetes mellitus was the leading cause of kidney failure. Left donor nephrectomy dominated in 83.3% of cases while right donor nephrectomy was performed in only 17.7%. Donor stay ranges from 5 to 6 days while recipients were discharged between 8 to 10 days. The 6 months and one year prognosis was excellent. 96.7% of recipient had improved QoL with return to normal life. Conclusion: Our impressive outcome was probably due to strictly adherence to our local protocol which includes good patient selection, complete HLA typing, cross matching and DSA quantitative analysis, legal documentation, early commencement of immunosuppression, experience transplant team, good surgical techniques, high dependency unit monitoring until discharge. Improving understanding of how to best address these indices can empower transplant centers with appreciable progress toward a worthwhile experience.